1. Inhalers currently prescribed in West Suffolk Linda Lord, Chief Pharmacist WSCCG

2. WSCCG Prescribing Data
Background
Top therapeutic areas
Top drugs
Inhaled corticosteroids (ICS)
Asthma and COPD combined
WSCCG data on inhalers
Practice data on inhalers

3. Background: Top therapeutic areas by spend
Rank
BNF Subparagraph
12-month spend
(March 16 – Feb 17) 1
Corticosteroid (respiratory)
£3,539,949 2
Control of epilepsy
£2,818,893 3
Opioid analgesics
£1,672,493

4. Background: Top drugs by spend
Rank
Drug
12-month spend
(March 16 – Feb 17) 1
Pregabalin
£962,268 2
Tiotropium (Spiriva)
£820,761 3
Pregabalin (Lyrica)
£753,569 4
Beclometasone/formoterol MDI (Fostair)
£730,215 5
Insulin Aspart (Novorapid)
£697,213 6
Budesonide/formoterol
(Symbicort Turbohaler)
£544,638

5. ICS - WSCCG vs National

6. ICS - spend per 1000 patients
(Feb 2017)
CCG spending least
CCG spending most
WSCCG
National

7. ICS - Spend/10,000 patients in practices (Feb 2017)

8. Inhalers - WSCCG March 16 – Feb 17
Total spend on all inhalers: £4.6m
Total spend on COPD inhalers: £1.4m
% (by cost) of COPD inhalers
‘in formulary’ varies by practice
Average = 66%

9. Inhalers - Practice Packs
ePACT prescribing data, latest 12 months
Information on COPD inhalers and all inhalers
Tool to promote best practice and improve cost effective prescribing
Which inhalers are prescribed at your practice?
Is there excessive prescribing of ICS for COPD at your practice?
Is there excessive prescribing of bronchodilators at your practice?
Are your COPD inhalers in-formulary or off-formulary?